Immediate Impact

1 from Science/Nature 50 standout
Sub-graph 1 of 25

Citing Papers

Precision nanomedicine: navigating the tumor microenvironment for enhanced cancer immunotherapy and targeted drug delivery
2025 Standout
Present and future of cancer nano-immunotherapy: opportunities, obstacles and challenges
2025 Standout
2 intermediate papers

Works of Mengna Zhan being referenced

Erlotinib overcomes paclitaxel-resistant cancer stem cells by blocking the EGFR-CREB/GRβ-IL-6 axis in MUC1-positive cervical cancer
2019
ANGPTL2/LILRB2 signaling promotes the propagation of lung cancer cells
2015

Author Peers

Author Last Decade Papers Cites
Mengna Zhan 246 197 34 73 13 354
Nanhang Lu 255 149 43 83 16 346
Wolong Zhou 287 149 69 89 21 393
Helga Simon‐Molas 244 193 22 83 18 373
Jintuan Huang 234 128 43 84 18 325
Xueqiang Ding 285 158 35 81 16 383
Wanli Ge 298 241 31 81 18 378
Justin Mastroianni 231 126 26 111 11 351
Ana Rita Lourenço 229 101 36 88 11 366
Linjing Yuan 206 152 25 75 15 336
Shao-Chieh Lin 147 104 45 105 15 346

All Works

Loading papers...

Rankless by CCL
2026